Ping An Good Doctor CEO He Mingke: Promoting the Sustainable Growth of Commercial Insurance Collaboration Business Through Two Major Initiatives

By The Daily Economic News Reporter | Tu Yinghao
By The Daily Economic News Editor | Wei Wenyi

On March 25 in Shanghai (reported by Tu Yinghao), at the performance briefing of Ping An Health Medical Technology Co., Ltd. (stock abbreviation: Ping An Good Doctor, HK01833, share price HK$13.00, market cap HK$28.099 billion), when Ping An Good Doctor’s CEO He Mingke answered a question from a reporter of The Daily Economic News about “the growth potential of the commercial insurance and healthcare synergy business and the company’s future deployment plans,” he said that it will focus on two major initiatives—reducing service costs and further improving service quality for high-end customers—so as to work to ensure the business continues to grow steadily.

Photo source: The Daily Economic News reporter Tu Yinghao

He Mingke said that at present the company’s service costs are too high to fully cover all customers and provide them with more high-quality benefits. The company will further optimize its cost structure and work to continuously expand market space. He also pointed out that within the industry, there is a commonly seen operating logic of building customer segments by means of a service system. By breaking through the quality ceiling of customized VIP service projects, a clear service gradient can be formed, which in turn can drive growth in the size of high-net-worth customer groups and strengthen competitiveness in servicing high-end customers.

The annual report shows that in 2025, Ping An Good Doctor achieved total revenue of RMB 5.468 billion, up 13.7%; profit attributable to shareholders of RMB 380 million, up 366.1%; and adjusted net profit of RMB 414 million, up 161.3%. In terms of business structure, the company’s largest revenue source—the commercial insurance and healthcare synergy business (F-end)—recorded revenue of RMB 3.296 billion, up 11%. The enterprise health management business (B-end) recorded revenue of RMB 1.306 billion, up 40.6%, with its revenue contribution increasing by 4.6 percentage points year over year to 23.9%.

Disclaimer: The content and data in this article are for reference only and do not constitute investment advice. Please verify before use. Any actions taken are at your own risk.

Cover image source: The Daily Economic News